Regeneron Pharmaceuticals (REGN) News Today $598.76 +29.85 (+5.25%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Regeneron Shares Are Up Today: What's Going On?April 30 at 4:36 PM | benzinga.comThe Manufacturers Life Insurance Company Purchases 18,366 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)The Manufacturers Life Insurance Company grew its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 5.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 356,410 shares of the biopharmaceutical company's sApril 30 at 7:50 AM | marketbeat.comRegeneron Pharmaceuticals Inc (REGN) Q1 2025 Earnings Call Highlights: Strong Dupixent Sales ...April 30 at 2:10 AM | gurufocus.comRegeneron's first-quarter results miss on lower Eylea demandApril 29 at 10:14 PM | msn.comRegeneron Pharmaceuticals Stock Sinks as Eylea Q1 Sales Trail EstimatesApril 29 at 10:14 PM | msn.comRegeneron Pharma Margins Tighten As Competition Grows, Stock SlidesApril 29 at 2:52 PM | benzinga.comTop Stock Movers Now: Honeywell, Sherwin-Williams, Regeneron, and MoreApril 29 at 12:06 PM | investopedia.comRegeneron Stock Plummets After Earnings MissApril 29 at 9:11 AM | barrons.comRegeneron Pharma's first-quarter results miss on lower Eylea demandApril 29 at 8:28 AM | reuters.comRegeneron Reports First Quarter 2025 Financial and Operating ResultsApril 29 at 6:30 AM | globenewswire.comNebula Research & Development LLC Sells 1,957 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Nebula Research & Development LLC trimmed its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 55.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,603 shares of theApril 29 at 5:59 AM | marketbeat.comPinebridge Investments L.P. Reduces Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Pinebridge Investments L.P. trimmed its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 85.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,970 shares of theApril 29 at 5:16 AM | marketbeat.comRegeneron Pharmaceuticals (REGN) Set to Announce Q1 EarningsApril 28 at 3:10 PM | gurufocus.comRegeneron Pharmaceuticals, Inc.: Lynozyfic (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple MyelomaApril 28 at 12:01 PM | finanznachrichten.deInsights into Regeneron Pharmaceuticals's Upcoming EarningsApril 28 at 12:01 PM | benzinga.comRegeneron Pharmaceuticals Receives Conditional Marketing Approval for Lynozyfic™ to Treat Relapsed/Refractory Multiple Myeloma in EuropeApril 28 at 7:19 AM | quiverquant.comRegeneron Pharmaceuticals Reports Initial Real-World Data on EYLEA HD Effectiveness for Retinal Diseases at ARVO 2025 Annual MeetingApril 28 at 7:19 AM | quiverquant.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Aquatic Capital Management LLCAquatic Capital Management LLC lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 128.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,081 shares of the biopharmaceutApril 28 at 7:02 AM | marketbeat.comLynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple MyelomaApril 28 at 7:01 AM | globenewswire.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Boothbay Fund Management LLCBoothbay Fund Management LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 989.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,375 shares of tApril 28 at 6:46 AM | marketbeat.comAdage Capital Partners GP L.L.C. Sells 125,290 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Adage Capital Partners GP L.L.C. lowered its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 73.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 44,349 shares of the biopharmaceutical company's stock after selling 125,April 28 at 5:37 AM | marketbeat.comRegeneron Pharmaceuticals (REGN) Expected to Announce Earnings on TuesdayApril 28 at 3:23 AM | americanbankingnews.comRobert W. Baird Has Lowered Expectations for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock PriceApril 28 at 2:21 AM | americanbankingnews.comRobert W. Baird Lowers Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $652.00Robert W. Baird dropped their price target on Regeneron Pharmaceuticals from $759.00 to $652.00 and set a "neutral" rating for the company in a research note on Friday.April 27 at 8:38 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Voya Investment Management LLCVoya Investment Management LLC lowered its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 17.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 153April 27 at 6:18 AM | marketbeat.comStifel Financial Corp Sells 10,159 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Stifel Financial Corp lowered its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 21.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 38,086 shares of the biopharmaceutical company's stock afterApril 27 at 5:20 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by MML Investors Services LLCMML Investors Services LLC lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 41.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,533 shares of the biopharmaceutical companyApril 27 at 5:00 AM | marketbeat.comMarket Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and HoldApril 26, 2025 | fool.comPrice T Rowe Associates Inc. MD Buys 810,144 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Price T Rowe Associates Inc. MD boosted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 63.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,085,447 shares of the biopharmaceuticaApril 26, 2025 | marketbeat.comRegeneron Pharmaceuticals (NASDAQ:REGN) Price Target Lowered to $975.00 at Truist FinancialApril 26, 2025 | americanbankingnews.comRegeneron price target lowered to $652 from $759 at BairdApril 25, 2025 | markets.businessinsider.comRegeneron Pharmaceuticals (NASDAQ:REGN) Stock Rating Upgraded by Canaccord Genuity GroupCanaccord Genuity Group upgraded shares of Regeneron Pharmaceuticals from a "hold" rating to a "strong-buy" rating in a report on Tuesday.April 25, 2025 | marketbeat.comNewEdge Advisors LLC Decreases Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)NewEdge Advisors LLC lowered its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 36.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,800 shares of the biopharmaceutical comApril 25, 2025 | marketbeat.comCantor Fitzgerald Predicts REGN FY2025 EarningsApril 25, 2025 | americanbankingnews.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Get Free Report) have earned an average recommendation of "Moderate Buy" from the twenty-six ratings firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, fiApril 25, 2025 | marketbeat.comRegeneron Pharmaceuticals (NASDAQ:REGN) Now Covered by Cantor FitzgeraldCantor Fitzgerald began coverage on Regeneron Pharmaceuticals in a report on Tuesday. They issued an "overweight" rating and a $695.00 price target for the company.April 24, 2025 | marketbeat.comRegeneron Pharmaceuticals (REGN) Projected to Post Earnings on TuesdayRegeneron Pharmaceuticals (NASDAQ:REGN) will be releasing its Q1 2025 earnings before the market opens on Tuesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-4-29-regeneron-pharmaceuticals-inc-stock/)April 24, 2025 | marketbeat.comJ. Safra Sarasin Holding AG Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)J. Safra Sarasin Holding AG purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 3,125 shares of the biopharmaceutical company'sApril 24, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by State of Tennessee Department of TreasuryState of Tennessee Department of Treasury lessened its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 4.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 37,200 sharesApril 24, 2025 | marketbeat.comVan Lanschot Kempen Investment Management N.V. Has $3.79 Million Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Van Lanschot Kempen Investment Management N.V. reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 15.2% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 5,318 shares of the biopharmaceutical companyApril 24, 2025 | marketbeat.comKayne Anderson Rudnick Investment Management LLC Sells 468 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Kayne Anderson Rudnick Investment Management LLC trimmed its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 8.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,278 shares of the biopharmaceuApril 24, 2025 | marketbeat.comRegeneron to invest over $3 billion to boost US manufacturingApril 24, 2025 | msn.comRegeneron Pharmaceuticals (NASDAQ:REGN) Now Covered by Analysts at Cantor FitzgeraldApril 24, 2025 | americanbankingnews.comRegeneron Pharmaceuticals (NASDAQ:REGN) Upgraded by Canaccord Genuity Group to Strong-Buy RatingApril 24, 2025 | americanbankingnews.comRegeneron price target lowered to $975 from $1,004 at TruistApril 23, 2025 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Intuitive Surgical (ISRG)April 23, 2025 | markets.businessinsider.comRegeneron Pharmaceuticals (NasdaqGS:REGN) Expands U.S. Capacity With US$3 Billion Fujifilm PartnershipApril 23, 2025 | finance.yahoo.comTower Research Capital LLC TRC Acquires 4,978 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Tower Research Capital LLC TRC raised its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 142.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,472 shares of the biopharmaceutical company's stock after buyiApril 23, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by BI Asset Management Fondsmaeglerselskab A SBI Asset Management Fondsmaeglerselskab A S grew its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 39.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,April 23, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Average Rating of "Moderate Buy" by AnalystsApril 23, 2025 | americanbankingnews.com Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address REGN Media Mentions By Week REGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼0.670.85▲Average Medical News Sentiment REGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼5829▲REGN Articles Average Week Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Vertex Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News BioMarin Pharmaceutical News Incyte News Exelixis News Neurocrine Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy REGN Stock Free REGN Stock Alerts